Citigroup Upgrades Mettler-Toledo International (NYSE:MTD) to Neutral

Mettler-Toledo International (NYSE:MTD - Get Free Report) was upgraded by stock analysts at Citigroup from a "sell" rating to a "neutral" rating in a report issued on Wednesday, MarketBeat Ratings reports. The brokerage currently has a $1,300.00 price objective on the medical instruments supplier's stock, up from their prior price objective of $1,200.00. Citigroup's target price would suggest a potential upside of 2.31% from the company's previous close.

MTD has been the subject of several other research reports. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating for the company in a report on Monday, November 11th. Stifel Nicolaus cut their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating for the company in a report on Monday, November 11th. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a research note on Tuesday, October 1st. Finally, Robert W. Baird dropped their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a research note on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $1,351.25.

Mettler-Toledo International Price Performance

Shares of NYSE MTD traded down $0.06 during mid-day trading on Wednesday, reaching $1,270.63. The company's stock had a trading volume of 79,867 shares, compared to its average volume of 135,796. The stock has a fifty day moving average of $1,317.66 and a two-hundred day moving average of $1,380.29. The firm has a market capitalization of $26.81 billion, a PE ratio of 34.25, a P/E/G ratio of 4.15 and a beta of 1.13. Mettler-Toledo International has a 52 week low of $1,103.73 and a 52 week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Analysts anticipate that Mettler-Toledo International will post 40.42 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the business's stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares of the company's stock, valued at $7,524.54. The trade was a 95.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the firm's stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds have recently made changes to their positions in the company. UMB Bank n.a. boosted its stake in shares of Mettler-Toledo International by 6.6% during the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier's stock valued at $158,000 after purchasing an additional 7 shares in the last quarter. DT Investment Partners LLC boosted its position in Mettler-Toledo International by 13.3% during the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier's stock valued at $102,000 after acquiring an additional 8 shares in the last quarter. Suncoast Equity Management increased its holdings in shares of Mettler-Toledo International by 2.0% in the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier's stock valued at $690,000 after acquiring an additional 9 shares during the period. Bleakley Financial Group LLC increased its holdings in shares of Mettler-Toledo International by 1.2% in the 3rd quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier's stock valued at $1,135,000 after acquiring an additional 9 shares during the period. Finally, Huntington National Bank raised its position in shares of Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier's stock worth $81,000 after acquiring an additional 9 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.